Routine: IBDEI34W

IBDEI34W ; ; 04-FEB-2020

 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020

 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y

Q Q

 ;;^UTILITY(U,$J,358.3,50054,1,4,0)

 ;;=4^L29.9

 ;;^UTILITY(U,$J,358.3,50054,2)

 ;;=^5009153

 ;;^UTILITY(U,$J,358.3,50055,0)

 ;;=L30.0^^193^2487^270

 ;;^UTILITY(U,$J,358.3,50055,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,50055,1,3,0)

 ;;=3^Nummular Dermatitis

 ;;^UTILITY(U,$J,358.3,50055,1,4,0)

 ;;=4^L30.0

 ;;^UTILITY(U,$J,358.3,50055,2)

 ;;=^186823

 ;;^UTILITY(U,$J,358.3,50056,0)

 ;;=L30.1^^193^2487^143

 ;;^UTILITY(U,$J,358.3,50056,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,50056,1,3,0)

 ;;=3^Dyshidrosis

 ;;^UTILITY(U,$J,358.3,50056,1,4,0)

 ;;=4^L30.1

 ;;^UTILITY(U,$J,358.3,50056,2)

 ;;=^5009154

 ;;^UTILITY(U,$J,358.3,50057,0)

 ;;=L30.2^^193^2487^135

 ;;^UTILITY(U,$J,358.3,50057,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,50057,1,3,0)

 ;;=3^Cutaneous Autosensitization

 ;;^UTILITY(U,$J,358.3,50057,1,4,0)

 ;;=4^L30.2

 ;;^UTILITY(U,$J,358.3,50057,2)

 ;;=^5009155

 ;;^UTILITY(U,$J,358.3,50058,0)

 ;;=L30.4^^193^2487^147

 ;;^UTILITY(U,$J,358.3,50058,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,50058,1,3,0)

 ;;=3^Erythema Intertrigo

 ;;^UTILITY(U,$J,358.3,50058,1,4,0)

 ;;=4^L30.4

 ;;^UTILITY(U,$J,358.3,50058,2)

 ;;=^5009157

 ;;^UTILITY(U,$J,358.3,50059,0)

 ;;=L30.8^^193^2487^138

 ;;^UTILITY(U,$J,358.3,50059,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,50059,1,3,0)

 ;;=3^Dermatitis NEC

 ;;^UTILITY(U,$J,358.3,50059,1,4,0)

 ;;=4^L30.8

 ;;^UTILITY(U,$J,358.3,50059,2)

 ;;=^5009158

 ;;^UTILITY(U,$J,358.3,50060,0)

 ;;=L30.9^^193^2487^139

 ;;^UTILITY(U,$J,358.3,50060,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,50060,1,3,0)

 ;;=3^Dermatitis,Unspec

 ;;^UTILITY(U,$J,358.3,50060,1,4,0)

 ;;=4^L30.9

 ;;^UTILITY(U,$J,358.3,50060,2)

 ;;=^5009159

 ;;^UTILITY(U,$J,358.3,50061,0)

 ;;=L40.0^^193^2487^293

 ;;^UTILITY(U,$J,358.3,50061,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,50061,1,3,0)

 ;;=3^Psoriasis Vulgaris

 ;;^UTILITY(U,$J,358.3,50061,1,4,0)

 ;;=4^L40.0

 ;;^UTILITY(U,$J,358.3,50061,2)

 ;;=^5009160

 ;;^UTILITY(U,$J,358.3,50062,0)

 ;;=L40.1^^193^2487^296

 ;;^UTILITY(U,$J,358.3,50062,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,50062,1,3,0)

 ;;=3^Pustulosis Psoriasis,Generalized

 ;;^UTILITY(U,$J,358.3,50062,1,4,0)

 ;;=4^L40.1

 ;;^UTILITY(U,$J,358.3,50062,2)

 ;;=^5009161

 ;;^UTILITY(U,$J,358.3,50063,0)

 ;;=L40.2^^193^2487^12

 ;;^UTILITY(U,$J,358.3,50063,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,50063,1,3,0)

 ;;=3^Acrodermatitis Continua

 ;;^UTILITY(U,$J,358.3,50063,1,4,0)

 ;;=4^L40.2

 ;;^UTILITY(U,$J,358.3,50063,2)

 ;;=^5009162

 ;;^UTILITY(U,$J,358.3,50064,0)

 ;;=L40.3^^193^2487^295

 ;;^UTILITY(U,$J,358.3,50064,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,50064,1,3,0)

 ;;=3^Pustulosis Palmaris et Plantaris

 ;;^UTILITY(U,$J,358.3,50064,1,4,0)

 ;;=4^L40.3

 ;;^UTILITY(U,$J,358.3,50064,2)

 ;;=^5009163

 ;;^UTILITY(U,$J,358.3,50065,0)

 ;;=L40.4^^193^2487^160

 ;;^UTILITY(U,$J,358.3,50065,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,50065,1,3,0)

 ;;=3^Guttate Psoriasis

 ;;^UTILITY(U,$J,358.3,50065,1,4,0)

 ;;=4^L40.4

 ;;^UTILITY(U,$J,358.3,50065,2)

 ;;=^5009164

 ;;^UTILITY(U,$J,358.3,50066,0)

 ;;=L40.8^^193^2487^292

 ;;^UTILITY(U,$J,358.3,50066,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,50066,1,3,0)

 ;;=3^Psoriasis NEC

 ;;^UTILITY(U,$J,358.3,50066,1,4,0)

 ;;=4^L40.8

 ;;^UTILITY(U,$J,358.3,50066,2)

 ;;=^271917

 ;;^UTILITY(U,$J,358.3,50067,0)

 ;;=L40.9^^193^2487^294

 ;;^UTILITY(U,$J,358.3,50067,1,0)

 ;;=^358.31IA^4^2

--- Routine Detail   --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI34W   3752     printed  Feb 19, 2025@00:08:18                                                                                                                                                                                                    Page 2

IBDEI34W  ; ; 04-FEB-2020

 +1       ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020

 +2        if 'DIFQR(358.3)

               QUIT

           FOR I=1:2

               SET X=$TEXT(Q+I)

               if X=""

                   QUIT

               SET Y=$EXTRACT($TEXT(Q+I+1),4,999)

               SET X=$EXTRACT(X,4,999)

               if $ASCII(Y)=126

                   SET I=I+1

                   SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)

               if $ASCII(Y)=61

                   SET Y=$EXTRACT(Y,2,999)

               XECUTE NO

              IF '$TEST

                   SET @X=Y

Q          QUIT

 +1       ;;^UTILITY(U,$J,358.3,50054,1,4,0)

 +2       ;;=4^L29.9

 +3       ;;^UTILITY(U,$J,358.3,50054,2)

 +4       ;;=^5009153

 +5       ;;^UTILITY(U,$J,358.3,50055,0)

 +6       ;;=L30.0^^193^2487^270

 +7       ;;^UTILITY(U,$J,358.3,50055,1,0)

 +8       ;;=^358.31IA^4^2

 +9       ;;^UTILITY(U,$J,358.3,50055,1,3,0)

 +10      ;;=3^Nummular Dermatitis

 +11      ;;^UTILITY(U,$J,358.3,50055,1,4,0)

 +12      ;;=4^L30.0

 +13      ;;^UTILITY(U,$J,358.3,50055,2)

 +14      ;;=^186823

 +15      ;;^UTILITY(U,$J,358.3,50056,0)

 +16      ;;=L30.1^^193^2487^143

 +17      ;;^UTILITY(U,$J,358.3,50056,1,0)

 +18      ;;=^358.31IA^4^2

 +19      ;;^UTILITY(U,$J,358.3,50056,1,3,0)

 +20      ;;=3^Dyshidrosis

 +21      ;;^UTILITY(U,$J,358.3,50056,1,4,0)

 +22      ;;=4^L30.1

 +23      ;;^UTILITY(U,$J,358.3,50056,2)

 +24      ;;=^5009154

 +25      ;;^UTILITY(U,$J,358.3,50057,0)

 +26      ;;=L30.2^^193^2487^135

 +27      ;;^UTILITY(U,$J,358.3,50057,1,0)

 +28      ;;=^358.31IA^4^2

 +29      ;;^UTILITY(U,$J,358.3,50057,1,3,0)

 +30      ;;=3^Cutaneous Autosensitization

 +31      ;;^UTILITY(U,$J,358.3,50057,1,4,0)

 +32      ;;=4^L30.2

 +33      ;;^UTILITY(U,$J,358.3,50057,2)

 +34      ;;=^5009155

 +35      ;;^UTILITY(U,$J,358.3,50058,0)

 +36      ;;=L30.4^^193^2487^147

 +37      ;;^UTILITY(U,$J,358.3,50058,1,0)

 +38      ;;=^358.31IA^4^2

 +39      ;;^UTILITY(U,$J,358.3,50058,1,3,0)

 +40      ;;=3^Erythema Intertrigo

 +41      ;;^UTILITY(U,$J,358.3,50058,1,4,0)

 +42      ;;=4^L30.4

 +43      ;;^UTILITY(U,$J,358.3,50058,2)

 +44      ;;=^5009157

 +45      ;;^UTILITY(U,$J,358.3,50059,0)

 +46      ;;=L30.8^^193^2487^138

 +47      ;;^UTILITY(U,$J,358.3,50059,1,0)

 +48      ;;=^358.31IA^4^2

 +49      ;;^UTILITY(U,$J,358.3,50059,1,3,0)

 +50      ;;=3^Dermatitis NEC

 +51      ;;^UTILITY(U,$J,358.3,50059,1,4,0)

 +52      ;;=4^L30.8

 +53      ;;^UTILITY(U,$J,358.3,50059,2)

 +54      ;;=^5009158

 +55      ;;^UTILITY(U,$J,358.3,50060,0)

 +56      ;;=L30.9^^193^2487^139

 +57      ;;^UTILITY(U,$J,358.3,50060,1,0)

 +58      ;;=^358.31IA^4^2

 +59      ;;^UTILITY(U,$J,358.3,50060,1,3,0)

 +60      ;;=3^Dermatitis,Unspec

 +61      ;;^UTILITY(U,$J,358.3,50060,1,4,0)

 +62      ;;=4^L30.9

 +63      ;;^UTILITY(U,$J,358.3,50060,2)

 +64      ;;=^5009159

 +65      ;;^UTILITY(U,$J,358.3,50061,0)

 +66      ;;=L40.0^^193^2487^293

 +67      ;;^UTILITY(U,$J,358.3,50061,1,0)

 +68      ;;=^358.31IA^4^2

 +69      ;;^UTILITY(U,$J,358.3,50061,1,3,0)

 +70      ;;=3^Psoriasis Vulgaris

 +71      ;;^UTILITY(U,$J,358.3,50061,1,4,0)

 +72      ;;=4^L40.0

 +73      ;;^UTILITY(U,$J,358.3,50061,2)

 +74      ;;=^5009160

 +75      ;;^UTILITY(U,$J,358.3,50062,0)

 +76      ;;=L40.1^^193^2487^296

 +77      ;;^UTILITY(U,$J,358.3,50062,1,0)

 +78      ;;=^358.31IA^4^2

 +79      ;;^UTILITY(U,$J,358.3,50062,1,3,0)

 +80      ;;=3^Pustulosis Psoriasis,Generalized

 +81      ;;^UTILITY(U,$J,358.3,50062,1,4,0)

 +82      ;;=4^L40.1

 +83      ;;^UTILITY(U,$J,358.3,50062,2)

 +84      ;;=^5009161

 +85      ;;^UTILITY(U,$J,358.3,50063,0)

 +86      ;;=L40.2^^193^2487^12

 +87      ;;^UTILITY(U,$J,358.3,50063,1,0)

 +88      ;;=^358.31IA^4^2

 +89      ;;^UTILITY(U,$J,358.3,50063,1,3,0)

 +90      ;;=3^Acrodermatitis Continua

 +91      ;;^UTILITY(U,$J,358.3,50063,1,4,0)

 +92      ;;=4^L40.2

 +93      ;;^UTILITY(U,$J,358.3,50063,2)

 +94      ;;=^5009162

 +95      ;;^UTILITY(U,$J,358.3,50064,0)

 +96      ;;=L40.3^^193^2487^295

 +97      ;;^UTILITY(U,$J,358.3,50064,1,0)

 +98      ;;=^358.31IA^4^2

 +99      ;;^UTILITY(U,$J,358.3,50064,1,3,0)

 +100     ;;=3^Pustulosis Palmaris et Plantaris

 +101     ;;^UTILITY(U,$J,358.3,50064,1,4,0)

 +102     ;;=4^L40.3

 +103     ;;^UTILITY(U,$J,358.3,50064,2)

 +104     ;;=^5009163

 +105     ;;^UTILITY(U,$J,358.3,50065,0)

 +106     ;;=L40.4^^193^2487^160

 +107     ;;^UTILITY(U,$J,358.3,50065,1,0)

 +108     ;;=^358.31IA^4^2

 +109     ;;^UTILITY(U,$J,358.3,50065,1,3,0)

 +110     ;;=3^Guttate Psoriasis

 +111     ;;^UTILITY(U,$J,358.3,50065,1,4,0)

 +112     ;;=4^L40.4

 +113     ;;^UTILITY(U,$J,358.3,50065,2)

 +114     ;;=^5009164

 +115     ;;^UTILITY(U,$J,358.3,50066,0)

 +116     ;;=L40.8^^193^2487^292

 +117     ;;^UTILITY(U,$J,358.3,50066,1,0)

 +118     ;;=^358.31IA^4^2

 +119     ;;^UTILITY(U,$J,358.3,50066,1,3,0)

 +120     ;;=3^Psoriasis NEC

 +121     ;;^UTILITY(U,$J,358.3,50066,1,4,0)

 +122     ;;=4^L40.8

 +123     ;;^UTILITY(U,$J,358.3,50066,2)

 +124     ;;=^271917

 +125     ;;^UTILITY(U,$J,358.3,50067,0)

 +126     ;;=L40.9^^193^2487^294

 +127     ;;^UTILITY(U,$J,358.3,50067,1,0)

 +128     ;;=^358.31IA^4^2

IBDEI34W.m